Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPPEIX, AmaliaMESQUITA, Claudio TinocoPAEZ, DianaPEREIRA, Carlos CunhaFELIX, RenataGUTIERREZ, ClaudiaJAIMOVICH, RodrigoIANNI, Barbara MariaSOARES JR., JoseOLAYA, PastorRODRIGUEZ, Ma VictoriaFLOTATS, AlbertGIUBBINI, RaffaeleTRAVIN, MarkGARCIA, Ernest V.2015-02-062015-02-062014NUCLEAR MEDICINE COMMUNICATIONS, v.35, n.8, p.818-823, 20140143-3636https://observatorio.fm.usp.br/handle/OPI/8774Heart failure is increasing worldwide at epidemic proportions, resulting in considerable disability, mortality, and increase in healthcare costs. Gated myocardial perfusion single photon emission computed tomography or PET imaging is the most prominent imaging modality capable of providing information on global and regional ventricular function, the presence of intraventricular synchronism, myocardial perfusion, and viability on the same test. In addition, I-123-mIBG scintigraphy is the only imaging technique approved by various regulatory agencies able to provide information regarding the adrenergic function of the heart. Therefore, both myocardial perfusion and adrenergic imaging are useful tools in the workup and management of heart failure patients. This guide is intended to reinforce the information on the use of nuclear cardiology techniques for the assessment of heart failure and associated myocardial disease. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.engrestrictedAccesscoronary artery diseasedilated cardiomyopathygated myocardial perfusion SPECTleft ventricular dyssynchronyMIBGPET imagingheart failurecardiac resynchronization therapyventricular mechanical dyssynchronymyocardial-perfusion spectphase-analysiscomputed-tomographydilated cardiomyopathycoronary-angiographyamerican-collegepredict responseprognostic valuearticleCopyright LIPPINCOTT WILLIAMS & WILKINS10.1097/MNM.0000000000000143Radiology, Nuclear Medicine & Medical Imaging1473-5628